BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16214811)

  • 21. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.
    Häcker H; Redecke V; Blagoev B; Kratchmarova I; Hsu LC; Wang GG; Kamps MP; Raz E; Wagner H; Häcker G; Mann M; Karin M
    Nature; 2006 Jan; 439(7073):204-7. PubMed ID: 16306937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.
    Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X
    Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9.
    Hoshino K; Sugiyama T; Matsumoto M; Tanaka T; Saito M; Hemmi H; Ohara O; Akira S; Kaisho T
    Nature; 2006 Apr; 440(7086):949-53. PubMed ID: 16612387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae.
    van der Graaf CA; Netea MG; Verschueren I; van der Meer JW; Kullberg BJ
    Infect Immun; 2005 Nov; 73(11):7458-64. PubMed ID: 16239547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous transforming growth factor-beta inhibits toll-like receptor mediated activation of human uterine natural killer cells.
    Eriksson M; Meadows SK; Wira CR; Sentman CL
    Am J Reprod Immunol; 2006; 56(5-6):321-8. PubMed ID: 17076676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.
    Zhang X; Jin J; Tang Y; Speer D; Sujkowska D; Markovic-Plese S
    J Immunol; 2009 Mar; 182(6):3928-36. PubMed ID: 19265172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A compass that points to lupus: genetic studies on type I interferon pathway.
    Kyogoku C; Tsuchiya N
    Genes Immun; 2007 Sep; 8(6):445-55. PubMed ID: 17581625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-like receptor function and signaling.
    Kaisho T; Akira S
    J Allergy Clin Immunol; 2006 May; 117(5):979-87; quiz 988. PubMed ID: 16675322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine signal transduction.
    Schindler C
    Receptor; 1995; 5(1):51-62. PubMed ID: 7613484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct functions of IRF-3 and IRF-7 in IFN-alpha gene regulation and control of anti-tumor activity in primary macrophages.
    Solis M; Goubau D; Romieu-Mourez R; Genin P; Civas A; Hiscott J
    Biochem Pharmacol; 2006 Nov; 72(11):1469-76. PubMed ID: 16846591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular regulation of interferon antiviral response in fish.
    Zhang YB; Gui JF
    Dev Comp Immunol; 2012 Oct; 38(2):193-202. PubMed ID: 22721905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-alpha in inflammation and immunity.
    Kaser A; Tilg H
    Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):609-17. PubMed ID: 11502069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The IRF family transcription factors at the interface of innate and adaptive immune responses.
    Ikushima H; Negishi H; Taniguchi T
    Cold Spring Harb Symp Quant Biol; 2013; 78():105-16. PubMed ID: 24092468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry.
    Brierley MM; Fish EN
    J Interferon Cytokine Res; 2002 Aug; 22(8):835-45. PubMed ID: 12396722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New aspects of IFN-alpha/beta signalling in immunity, oncogenesis and bone metabolism.
    Takaoka A; Taniguchi T
    Cancer Sci; 2003 May; 94(5):405-11. PubMed ID: 12824884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Illuminating the role of type I IFNs in colitis.
    Wirtz S; Neurath MF
    J Clin Invest; 2005 Mar; 115(3):586-8. PubMed ID: 15765141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of evasion of the type I interferon antiviral response by flaviviruses.
    Diamond MS
    J Interferon Cytokine Res; 2009 Sep; 29(9):521-30. PubMed ID: 19694536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of type I interferons in non-viral infections.
    Bogdan C; Mattner J; Schleicher U
    Immunol Rev; 2004 Dec; 202():33-48. PubMed ID: 15546384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of interferon regulatory factor-mediated signaling in psoriasis.
    Wang WM; Li F; Jin HZ
    Int J Med Sci; 2021; 18(16):3794-3799. PubMed ID: 34790055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IFN-
    Karimi Y; Giles EC; Vahedi F; Chew MV; Nham T; Loukov D; Lee AJ; Bowdish DM; Ashkar AA
    Innate Immun; 2020 Apr; 26(3):172-182. PubMed ID: 31615311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.